BIOVAIL BUYS PUERTO-RICAN FIRM
By Adnews Staff
Biovail Corp. International of Toronto has bought Puerto Rican drug company Galephar P.R. for $10 million. The deal gives Biovail the rights to sell the heart drug Tiazac in the U.S. and Europe. While Tiazac was under development, Biovail obtained some rights to it from Galephar. Advertising for Biovail is done by Sudler & Hennessey/Gall of Montreal. The company invests and markets new controlled-release versions of popular name-brand drugs. Currently, it produces 11 drugs.
« Back Next »
Comments
blog comments powered by Disqus